Merit Medical Systems, Inc.

Equities

MMSI

US5898891040

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:30:00 2024-05-03 pm EDT 5-day change 1st Jan Change
78.97 USD +2.53% Intraday chart for Merit Medical Systems, Inc. +7.62% +3.96%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Barrington Raises Adjusts Price Target on Merit Medical Systems to $100 From $98, Maintains Outperform Rating MT
Transcript : Merit Medical Systems, Inc., Q1 2024 Earnings Call, Apr 30, 2024
(MMSI) MERIT MEDICAL SYSTEMS Sees Fiscal Year 2024 EPS Range $3.28 - $3.35 MT
Earnings Flash (MMSI) MERIT MEDICAL SYSTEMS Reports Q1 Revenue $323.5M, vs. Street Est of $315.9M MT
Earnings Flash (MMSI) MERIT MEDICAL SYSTEMS Reports Q1 EPS $0.77, vs. Street Est of $0.72 MT
Merit Medical Systems, Inc. Reaffirms Sales Guidance for the Year Ending December 31, 2024 CI
Merit Medical Systems, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Merit Medical Launches Micro ACE Micro-Access System in US MT
Merit Medical Systems, Inc. Launches the Micro Ace Advanced Micro-Access System CI
Merit Medical Systems Insider Sold Shares Worth $479,182, According to a Recent SEC Filing MT
Merit Medical Systems Insider Sold Shares Worth $1,891,925, According to a Recent SEC Filing MT
Merit Medical Systems Insider Sold Shares Worth $1,380,513, According to a Recent SEC Filing MT
Needham Ups Price Target on Merit Medical Systems to $88 From $81, Maintains Buy Rating MT
Barrington Ups Price Target on Merit Medical Systems to $98 From $96, Maintains Outperform Rating MT
Oppenheimer Raises Merit Medical Systems Price Target to $87 From $82, Maintains Outperform Rating MT
Merit Medical Systems Q4 Non-GAAP Earnings, Revenue Advance MT
Transcript : Merit Medical Systems, Inc., Q4 2023 Earnings Call, Feb 28, 2024
(MMSI) MERIT MEDICAL SYSTEMS Expects Fiscal Year 2024 EPS Range $3.28 - $3.35 MT
Earnings Flash (MMSI) MERIT MEDICAL SYSTEMS Reports Q4 Revenue $324.5M, vs. Street Est of $320.6M MT
Earnings Flash (MMSI) MERIT MEDICAL SYSTEMS Posts Q4 EPS $0.81, vs. Street Est of $0.77 MT
Merit Medical Systems, Inc. Provides Earnings Guidance for the Year Ending December 31, 2024 CI
Merit Medical Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Merit Medical Systems, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Merit Medical Systems Gets FDA Clearance For New Surgical Guidance System MT
Merit Medical Systems, Inc. Receives FDA 510(K) Clearance for Scout MD Surgical Guidance System CI
Chart Merit Medical Systems, Inc.
More charts
Merit Medical Systems, Inc. designs, develops, manufactures, markets and sells medical products for interventional and diagnostic procedures. The Company is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions and original equipment manufacturer. Within these product categories, it sells a variety of products, including cardiology and radiology devices, as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care and others. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
77.02 USD
Average target price
92 USD
Spread / Average Target
+19.45%
Consensus
  1. Stock Market
  2. Equities
  3. MMSI Stock
  4. News Merit Medical Systems, Inc.
  5. Raymond James Adjusts Price Target on Merit Medical Systems to $89 From $84, Keeps Outperform Rating